Stay updated on GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Sign up to get notified when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.

Latest updates to the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference3%
- Check20 days agoChange DetectedRenaming a medical condition to a more precise term and updating versioning from v3.0.2 to v3.1.0; older terms and unrelated melanoma entry removed.SummaryDifference0.8%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpdated from v3.0.1 to v3.0.2, indicating a minor update. The Back to Top element was removed, while core content and pricing remain unchanged.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has been updated to include new resources related to various cancers and immunotherapy, while removing some previous cancer-related topics and specific location details.SummaryDifference8%
- Check56 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
Stay in the know with updates to GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEN-009 Vaccine Safety, Immunogenicity in Clinical Trial page.